[{"Assets_0_Q2_USD":1783400000.0,"CommonStockSharesOutstanding_0_Q2_shares":47653527.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-55000000.0,"NetIncomeLoss_1_Q2_USD":-8000000.0,"NetIncomeLoss_2_Q2_USD":-28300000.0,"StockholdersEquity_0_Q2_USD":1276900000.0,"EarningsPerShareBasic_1_Q2_USD":-0.17,"EarningsPerShareBasic_2_Q2_USD":-0.6,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":47600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":47500000.0,"Ticker":"AVNS","CIK":"1606498","name":"AVANOS MEDICAL, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20190806"}]